Precision BioSciences Inc (DTIL) — Capital Reinvestment Ratio

Latest as of September 2022: 0.04x

Precision BioSciences Inc (DTIL) has a Capital Reinvestment Ratio of 0.04x as of September 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($1.09 Million). Check DTIL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

$29.19 Million
USD

Capital Expenditures

$1.09 Million
USD

Data as of

Sep 2022
Most recent filing

Precision BioSciences Inc Capital Reinvestment Ratio (2016–2016)

This chart tracks Precision BioSciences Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see DTIL operating cash flow.

Annual Capital Reinvestment Ratio for Precision BioSciences Inc (2016–2016)

Year-by-year Capital Reinvestment Ratio for Precision BioSciences Inc from 2016 to 2016. See how much free cash does Precision BioSciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2016 0.02x $92.27 Million $2.08 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow